Safety of endoscopic ultrasound-guided hepaticogastrostomy in patients with malignant biliary obstruction and ascites.
Autorzy:
Yasuda T; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Hara K; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. MizunoN; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Haba S; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Kuwahara T; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Okuno N; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Kuraishi Y; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Yanaidani T; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Ishikawa S; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Yamada M; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Fukui T; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
Pokaż więcej
Źródło:
Clinical endoscopy [Clin Endosc] 2024 Mar; Vol. 57 (2), pp. 246-252. Date of Electronic Publication: 2023 Sep 07.
GPR56 C-terminal fragment mediates signal received by N-terminal fragment of another adhesion GPCR Latrophilin1 in neurons.
Autorzy:
Nojima Y; Laboratory of Molecular Signal Transduction, Division of Biological Science, Nara Institute of Science and Technology, Nara, Japan. Toriyama M; Laboratory of Molecular Signal Transduction, Division of Biological Science, Nara Institute of Science and Technology, Nara, Japan. Tago K; Division of Structural Biochemistry, Department of Biochemistry, Jichi Medical University, Tochigi, Japan. MizunoN; Faculty of Pharmaceutical Sciences, Aomori University, Aomori, Japan. Morishita K; Project for Advanced Medical Research and Development, Project Research Division, Frontier Science Research Center, University of Miyazaki, Miyazaki, Japan. Itoh H; Laboratory of Molecular Signal Transduction, Division of Biological Science, Nara Institute of Science and Technology, Nara, Japan.
Refractory benign biliary stricture due to chronic pancreatitis in two patients treated using endoscopic ultrasound-guided choledochoduodenostomy fistula creation: case reports.
Autorzy:
Ishikawa S; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Okuno N; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Hara K; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. MizunoN; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Haba S; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Kuwahara T; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Kuraishi Y; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Yanaidani T; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
Pokaż więcej
Źródło:
Clinical endoscopy [Clin Endosc] 2024 Jan; Vol. 57 (1), pp. 122-127. Date of Electronic Publication: 2023 May 16.
Development of a nomogram to predict survival in advanced biliary tract cancer.
Autorzy:
Imaoka H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. . Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. Nomura S; Japan Clinical Oncology Group Data Center, Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan. Morizane C; Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan. Okusaka T; Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan. Ozaka M; Hepato-Biliary-Pancreatic Medicine Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. Shimizu S; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan. Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan. Okano N; Department of Medical Oncology, Faculty of Medicine, Kyorin University, Tokyo, Japan. Sugimori K; Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan. Shirakawa H; Department of Medical Oncology, Tochigi Cancer Center, Utsunomiya, Japan. MizunoN; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Satoi S; Division of Pancreatobiliary Surgery, Department of Surgery, Kansai Medical University, Hirakata, Japan. Yamaguchi H; Department of Clinical Oncology, Jichi Medical University, Shimotsuke, Japan. Sugimoto R; Department of Hepato-Biliary-Pancreatology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan. Gotoh K; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. Sano K; Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan. Asagi A; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan. Nakamura K; Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan. Ueno M; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Yokohama, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 06; Vol. 13 (1), pp. 21548. Date of Electronic Publication: 2023 Dec 06.
Mayaro virus pathogenesis and immunity in rhesus macaques.
Autorzy:
Weber WC; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, United States of America. Labriola CS; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America. Kreklywich CN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America. Ray K; Bioinformatics & Biostatistics Core, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America. Haese NN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America. Andoh TF; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America. Denton M; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America. Medica S; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, United States of America. Streblow MM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America. Smith PP; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America. MizunoN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America. Frias N; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America. Fisher MB; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America. Barber-Axthelm AM; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America. Chun K; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America. Uttke S; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America. Whitcomb D; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America. DeFilippis V; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America. Rakshe S; Bioinformatics & Biostatistics Core, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America. Fei SS; Bioinformatics & Biostatistics Core, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America. Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America. Smedley JV; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America. Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Nov 20; Vol. 17 (11), pp. e0011742. Date of Electronic Publication: 2023 Nov 20 (Print Publication: 2023).
Safety and feasibility of opening window fistulotomy as a new precutting technique for primary biliary access in endoscopic retrograde cholangiopancreatography.
Autorzy:
Kuraishi Y; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Hara K; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Haba S; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Kuwahara T; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Okuno N; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Yanaidani T; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Ishikawa S; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Yasuda T; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. Yamada M; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. MizunoN; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
Pokaż więcej
Źródło:
Clinical endoscopy [Clin Endosc] 2023 Jul; Vol. 56 (4), pp. 490-498. Date of Electronic Publication: 2023 Apr 27.
Comparison of bacterial profiles in human milk from mothers of term and preterm infants.
Autorzy:
Miura K; The Nippon Foundation Human Milk Bank, Nihonbashi-koamicho Square Building 1F, 17-10 Nihonbashi-koamicho, Chuo-ku, Tokyo, 103-0016, Japan.; Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita, 879-5593, Japan. Tanaka M; The Nippon Foundation Human Milk Bank, Nihonbashi-koamicho Square Building 1F, 17-10 Nihonbashi-koamicho, Chuo-ku, Tokyo, 103-0016, Japan. Date M; The Nippon Foundation Human Milk Bank, Nihonbashi-koamicho Square Building 1F, 17-10 Nihonbashi-koamicho, Chuo-ku, Tokyo, 103-0016, Japan. Ito M; The Nippon Foundation Human Milk Bank, Nihonbashi-koamicho Square Building 1F, 17-10 Nihonbashi-koamicho, Chuo-ku, Tokyo, 103-0016, Japan. MizunoN; Japan Human Milk Bank Association, 4-4 Nihonbashi-Hisamatsucho, Chuo-ku, Tokyo, 103-8480, Japan. Mizuno K; The Nippon Foundation Human Milk Bank, Nihonbashi-koamicho Square Building 1F, 17-10 Nihonbashi-koamicho, Chuo-ku, Tokyo, 103-0016, Japan. .; Japan Human Milk Bank Association, 4-4 Nihonbashi-Hisamatsucho, Chuo-ku, Tokyo, 103-8480, Japan. .; Department of Pediatrics, Showa University of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan. .
FIGHT-102: A phase 1 study of pemigatinib in Japanese patients with advanced malignancies.
Autorzy:
Fujiwara Y; National Cancer Center Hospital, Tokyo, Japan.; Aichi Cancer Center, Nagoya, Japan. Kuboki Y; National Cancer Central Hospital East, Chiba, Japan. Furukawa M; Kyushu Cancer Center, Fukuoka, Japan. MizunoN; Aichi Cancer Center, Nagoya, Japan. Hara H; Saitama Cancer Center, Saitama, Japan. Ioka T; Department of Oncology Center, Yamaguchi University Hospital, Ube, Japan. Ueno M; Kanagawa Cancer Center, Yokohama, Japan. Takahashi Y; Hokkaido Cancer Center, Sapporo, Japan. Takahashi S; Cancer Institute Hospital of JFCR, Tokyo, Japan. Takeuchi S; Kanazawa University Hospital, Kanazawa, Japan. Lihou C; Incyte Corporation, Wilmington, Delaware, USA. Ji T; Incyte Corporation, Wilmington, Delaware, USA. Tian C; Incyte Corporation, Wilmington, Delaware, USA. Shimizu T; National Cancer Center Hospital, Tokyo, Japan.; Wakayama Medical University, Wakayama, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 May; Vol. 12 (9), pp. 10597-10611. Date of Electronic Publication: 2023 Mar 31.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Role of Endoscopic Ultrasound and Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Diagnosing Metastasis to the Pancreas: A Tertiary Center Experience
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
